UK markets closed

Inhibitor Therapeutics, Inc. (INTI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.12060.0000 (0.00%)
At close: 11:24AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
6.225
1,381
6.15
4.905
185.294
Selling general and administrative
256.825
2,024
651.776
320.49
873.703
Total operating expenses
263.05
3,405
657.926
325.395
1,059
Operating income or loss
-263.05
-3,405
-657.926
-325.395
-1,059
Interest expense
24.68
0
23.234
14.837
-
Total other income/expenses net
-
-
12,842
41.6
-
Income before tax
-287.73
-3,026
12,161
-298.632
-1,058
Income tax expense
0
0
55.109
0
-
Income from continuing operations
-287.73
-3,026
12,106
-298.632
-1,058
Net income
-287.73
-3,026
12,106
-298.632
-1,058
Net income available to common shareholders
-487.731
-3,026
11,917
-498.633
-1,258
Basic EPS
-0.00
-0.02
0.03
-0.00
-0.00
Diluted EPS
-0.00
-0.02
0.03
-0.00
-0.00
Basic average shares
376,248
171,950
366,184
376,248
371,928
Diluted average shares
376,858
171,950
366,184
376,248
371,928